Lebenthal Asset Management »

United Therapeutics Corporation shares owned by Lebenthal Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Lebenthal Asset Management from 13F filings

Historical chart of Lebenthal Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Lebenthal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Lebenthal Asset Management

Quarter filed Position value Share count Share price at filing
2017-03-31 $495k 3.7k 135.39

More positions owned by Lebenthal Asset Management

Apple (AAPL)
Exxon Mobil Corporation (XOM)
International Business Machines (IBM)
Nextera Energy (NEE)
Chevron Corporation (CVX)
General Electric Company
Johnson & Johnson (JNJ)
Wells Fargo & Company (WFC)
Berkshire Hathaway (BRK.A)
Intel Corporation (INTC)
Abbvie (ABBV)
Qualcomm (QCOM)
Home Depot (HD)
Bristol Myers Squibb (BMY)
Walgreen Boots Alliance (WBA)

View all positions for Lebenthal Asset Management

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
AQR Capital Management
Bank of New York Mellon
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
LSV Asset Management
Charles Schwab Investment Management
Pacer Advisors
Nordea Investment Management Ab
Caisse de depot et placement du Quebec

View all funds holding United Therapeutics Corporation